1. Skip to navigation
  2. Skip to content
  3. Skip to sidebar

Consumer Affairs

Researchers Find Brain Receptor that Responds to Nicotine

Targeting the receptor could reduce weight gain after the smoke clears


photoStop smoking? Sure, but what if you start packing on the pounds? That's been the curse of smoking cessation for many, but now a new study holds out hope of being able to stop smoking without gaining weight.

Researchers funded by the National Institute of Health (NIH) say they've found a brain mechanism – called a nicotonic receptor -- that's involved in nicotine's ability to reduce food intake in rodents.

In the study, to be published in the June 10 issue of Science, researchers found that a nicotine-like drug, cytisine, specifically activated nicotinic receptors in the hypothalamus — a brain center that controls feeding.

This resulted in the activation of a circuit that reduced food intake and body fat in a mouse model. This effect was very specific, since a drug that prevented cytisine from binding to its hypothalamic receptors blocked the reduction in food intake.

Prior research shows that the average weight gain after smoking is less than 10 pounds, but even so, fear of weight gain can discourage some people who would like to quit even though smoking is much worse than being a few pounds overweight.

Through the use of tobacco, nicotine is one of the most heavily used addictive drugs and the leading preventable cause of disease, disability, and death in the United States. According to the Centers for Disease Control and Prevention, cigarette smoking results in more than 440,000 preventable deaths each year — about 1 in 5 U.S. deaths overall. Despite the well-documented health costs of smoking, many smokers report great difficulty quitting.

Mouse model

"These mouse models allow us to explore the mechanisms through which nicotine acts in the brain to reduce food intake," said Dr. Marina Picciotto, of Yale University, New Haven, Conn. and senior author for the article. "We found that nicotine reduced eating and body fat through receptors implicated in nicotine aversion and withdrawal rather than reward and reinforcement."

"These results indicate that medications that specifically target this pathway could alleviate nicotine withdrawal as well as reduce the risk of overeating during smoking cessation," said NIDA Director Dr. Nora D. Volkow. "Although more research is warranted, such a highly selective compound might be more effective than drugs that act on more than one type of nicotinic receptor."

For information on tips to maintain a healthy weight while quitting smoking go to Forever Free: Smoking and Weight, a publication of the National Cancer Institute.

 

 

Quantcast